ORBIMED ADVISORS LLC Biohaven Pharmaceutical Holding Company Ltd. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$25.81M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+3.75%
quarter

Biohaven Pharmaceutical Holding Company Ltd. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -76.25% -548.26K shares -78.95M $151.17 170.76K
Q2 2022 share 0.00% 0 shares 19.51M $145.71 719.03K
Q1 2022 share Increase 0.00% 719.03K shares 85.25M $118.57 719.03K
Q2 2018 put Decrease -100.00% -50K shares -1.28M $39.52 0
Q1 2018 put Increase 0.00% 50K shares 1.28M $25.76 50K